Get the Stockscreener App
34.26
2.78%
-0.98
After Hours:
34.32
0.06
+0.18%
Alkermes Plc Stock (ALKS) Latest News
Alkermes Plc to Host Earnings Call - ACCESS Newswire
Alkermes plc (NASDAQ:ALKS) Shares Bought by Smartleaf Asset Management LLC - Defense World
Proficio Capital Partners LLC Buys New Stake in Alkermes plc (NASDAQ:ALKS) - Defense World
(ALKS) Technical Pivots with Risk Controls - Stock Traders Daily
What is Zacks Research’s Estimate for Alkermes Q1 Earnings? - Defense World
Zacks Research Predicts Alkermes FY2027 Earnings - Defense World
Y Intercept Hong Kong Ltd Invests $413,000 in Alkermes plc (NASDAQ:ALKS) - MarketBeat
UBS Upgrades Alkermes (ALKS) - Nasdaq
Bank of New York Mellon Corp Has $61.45 Million Stock Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World
Alkermes (NASDAQ:ALKS) Upgraded to Neutral at UBS Group - Defense World
UBS Upgrades Alkermes to Neutral From Sell, $38 Price Target -March 04, 2025 at 08:27 am EST - Marketscreener.com
Alkermes upgraded to Neutral from Sell at UBS - TipRanks
Alkermes plc (ALKS): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
New York State Common Retirement Fund Increases Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World
Ieq Capital LLC Acquires New Stake in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes VP Samuel Parisi sells $65,892 in shares - Investing.com
Alkermes VP Samuel Parisi sells $65,892 in shares By Investing.com - Investing.com UK
Illinois Municipal Retirement Fund Sells 11,878 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes plc (NASDAQ:ALKS) is HealthInvest Partners AB's 10th Largest Position - MarketBeat
C WorldWide Group Holding A S Purchases Shares of 250,000 Alkermes plc (NASDAQ:ALKS) - MarketBeat
Todd Asset Management LLC Sells 30,957 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Sanctuary Advisors LLC Acquires 1,917 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
Alkermes to Participate in Upcoming Investor Conferences - PR Newswire UK
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Alkermes plc To Contact The Firm - ACCESS Newswire
Blue Trust Inc. Purchases 1,629 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World
Alkermes VP of finance Samuel Joseph Parisi sells shares worth $131,978 By Investing.com - Investing.com South Africa
Alkermes VP of finance Samuel Joseph Parisi sells shares worth $131,978 - Investing.com India
Trading (ALKS) With Integrated Risk Controls - Stock Traders Daily
Alkermes’ Neuroscience Pivot: ALKS 2680 Set To Revolutionize Narcolepsy Treatment (ALKS) - Seeking Alpha
Alkermes plc (NASDAQ:ALKS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Hussman Strategic Advisors Inc. Takes Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Van ECK Associates Corp Purchases 32,581 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes (NASDAQ:ALKS) Hits New 1-Year HighHere's Why - MarketBeat
Alkermes plc (NASDAQ:ALKS) Holdings Reduced by Rice Hall James & Associates LLC - MarketBeat
Alkermes plc VP Samuel Joseph Parisi sells $47,360 in stock By Investing.com - Investing.com South Africa
Alkermes plc VP Samuel Joseph Parisi sells $47,360 in stock - Investing.com India
Craig C. Hopkinson Sells 144,419 Shares of Alkermes plc (NASDAQ:ALKS) Stock - MarketBeat
Alkermes (NASDAQ:ALKS) Price Target Raised to $32.00 - MarketBeat
Opioid Use Disorder Treatment Market Size in the 7MM was around - openPR
Vontobel Holding Ltd. Sells 7,982 Shares of Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes (NASDAQ:ALKS) Receives "Neutral" Rating from HC Wainwright - MarketBeat
Alkermes (NASDAQ:ALKS) Rating Increased to Strong-Buy at StockNews.com - MarketBeat
Equities Analysts Offer Predictions for Alkermes Q1 Earnings - Defense World
HC Wainwright Issues Negative Estimate for Alkermes Earnings - MarketBeat
Alkermes (ALKS) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Alkermes (NASDAQ:ALKS) Updates FY 2025 Earnings Guidance - MarketBeat
Alkermes Plc EPS Soars Past Forecasts - AOL
Alkermes plc Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next - Yahoo Finance
How to Take Advantage of moves in (ALKS) - Stock Traders Daily
Alkermes targets $310M-$340M adjusted EBITDA amid LYBALVI growth and orexin pipeline expansion - MSN
Alkermes (NASDAQ:ALKS) Earns Buy Rating from Analysts at Deutsche Bank Aktiengesellschaft - MarketBeat
Alkermes plc. Officer Sells Shares Worth Over $11 Million - TradingView
Earnings call transcript: Alkermes Q4 2024 beats EPS forecasts, stock rises - MSN
7.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):